Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Canada could benefit from looking at how Argentina and others have approached gene editing in livestock and its effect on ...
Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
How can altering DNA help defeat one of the world’s deadliest diseases? This video explores how scientists are using CRISPR ...
The US FDA is set to introduce a faster approval process for personalized gene editing therapies, aiming to accelerate investment and development of treatments for rare diseases, highlighted by the ...
Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...
Samsung Group said Thursday it will invest in Arbor Biotechnologies, a US-based gene editing company, through its Life ...
Samsung is proceeding with an investment in U.S.-based Arbor Biotechnologies (Arbor Bio), a company specializing in ...
Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...